Evaluation of In Vitro and In Vivo Antidiabetic Activity of  Ethanolic Root Extract of Cassia Fistula L. on Streptozotocin Induced Diabetic Rats by Soundiramani, B
EVALUATION OF IN VITRO AND IN VIVO ANTIDIABETIC ACTIVITY OF 
ETHANOLIC ROOT EXTRACT OF Cassia fistula L. ON STREPTOZOTOCIN 
INDUCED DIABETIC RATS 
 
A dissertation submitted to 
THE TAMILNADU DR.M.G.R MEDICAL UNIVERSITY 
CHENNAI - 600 032. 
In the partial fulfillment of the requirements 
for the award of the degree of 
MASTER OF PHARMACY 
IN 
PHARMACOLOGY 
Submitted by 
Reg. No: 261426069 
Under the guidance of 
Mrs. R. INDUMATHY, M. Pharm., 
 
 
INSTITUTE OF PHARMACOLOGY 
MADRAS MEDICAL COLLEGE 
CHENNAI - 600 003 
APRIL – 2016 
CERTIFICATE 
 
          This is to certify that the dissertation entitled “EVALUATION OF IN 
VITRO AND IN VIVO ANTI-DIABETIC ACTIVITY OF ETHANOLIC 
ROOT EXTRACT OF Cassia fistula Linn. ON STREPTOZOTOCIN 
INDUCED DIABETES IN RATS” submitted by Registration No. 261426069 in 
partial fulfillment of the requirements for the award of Degree of Master of 
Pharmacy in Pharmacology by the Tamil Nadu Dr.M.G.R. Medical University, 
Chennai is a bonafide work done by her in the institute of Pharmacology, Madras 
Medical College, Chennai during the academic year 2015-2016 under the 
guidance of  Mrs. R. Indumathy, M. Pharm., Assistant professor in Pharmacy, 
Institute of Pharmacology, Madras Medical College, Chennai-600 003. 
 
 
 
                                                                                                                     The Dean, 
      Place: Chennai-03.                                                             Madras Medical College, 
      Date:                                                                                   Chennai -  600 003. 
 
 
 
                                                      
                                                        
CERTIFICATE 
 
                  This is to certify that the dissertation entitled “EVALUATION OF IN 
VITRO AND IN VIVO ANTI-DIABETIC ACTIVITY OF ETHANOLIC 
ROOT EXTRACT OF Cassia fistula Linn. ON STREPTOZOTOCIN 
INDUCED DIABETES IN RATS” submitted by Registration No. 261426069 in 
partial fulfillment of the requirements for the award of Degree of Master of  
Pharmacy in Pharmacology by the Tamil Nadu  Dr.M.G.R. Medical University, 
Chennai is a bonafide work done by her in the institute of Pharmacology, Madras 
Medical College, Chennai during the academic year 2015-2016 under the 
guidance of  Mrs. R. Indumathy, M. Pharm., Assistant professor in Pharmacy, 
Institute of Pharmacology, Madras Medical College, Chennai-600 003. 
 .  
 
 
 
                                                                                        The Director and HOD, 
                                                                                           Institute of Pharmacology, 
        Place: Chennai-03.                                                     Madras Medical College, 
        Date:                                                                           Chennai-600 003. 
                         
                                         
                                           
CERTIFICATE 
 
                     This is to certify that the dissertation entitled “EVALUATION OF 
IN VITRO AND IN VIVO ANTI-DIABETIC ACTIVITY OF ETHANOLIC 
ROOT EXTRACT OF Cassia fistula Linn. ON STREPTOZOTOCIN 
INDUCED DIABETES IN RATS” submitted by Registration No. 261426069 in 
partial fulfillment of the requirements for the award of Degree of Master of  
Pharmacy in Pharmacology by the Tamil Nadu  Dr.M.G.R. Medical University, 
Chennai is a bonafide work done by her in the institute of Pharmacology, Madras 
Medical College, Chennai  during the academic year 2015-2016 under my 
guidance. 
  
 
 
                                                                                             Mrs. R. Indumathy, M. Pharm., 
                                                                                Assistant professor in Pharmacy, 
      Place: Chennai-03.                                           Institute of Pharmacology, 
      Date:                                                                 Madras Medical College, 
                                                                                Chennai- 600 003. 
 ACKNOWLEDGEMENT 
 
    Though words are seldom sufficient to express my gratitude and feelings. It 
somehow gives an opportunity to thank those who helped me during the tenure of my 
study. 
            I express my honourable thanks to The Dean, Dr.R. Vimala, M.D., Madras 
Medical College, for permitting me to undertake the project during the period of my 
academic study.  
I would like to thank   Dr. A. Jerad Suresh, M. Pharm., Ph.D., M.B.A., The 
Principle & Head of the department, Department of pharmaceutical chemistry, 
College of Pharmacy, Madras Medical College, Chennai-03 for support during my 
project work. 
           I acknowledge my sincere thanks to Professor Dr. B. Vasanthi M.D., The 
Director and Professor, Institute of Pharmacology, Madras Medical College for her 
immense support and encouragement throughout the project.  
           I extend my heartfelt gratitude to Prof. Dr. N. Jayshree, M.pharm., Ph.D., 
Professor, Institute of Pharmacology, Madras Medical College for her continuous 
support in carrying out my dissertation work in this institution. 
            It is a great privilege to honour and convey my gratitude to Mrs. R. 
Indumathy, M. Pharm., Assistant professor in pharmacy, Institute of Pharmacology, 
Madras Medical College, for her guidance, clearing the path towards completion of 
my project. 
            My sincere thanks to prof. Dr. K. M. Sudha, M.D., Professor, Institute of 
Pharmacology, Madras Medical College, for her support throughout the project work. 
            I would like to thank Mrs. M. Sakthi Abirami, M. Pharm., Assistant 
professor in Pharmacy, Institute of Pharmacology, Madras Medical College for her 
help rendered during the study.  
            I would like to thank Mr. V. Sivaraman, M. Pharm., Assistant Professor in 
pharmacy, Institute of Pharmacology, Institute of Pharmacology, Madras Medical 
College for him help rendered during the study. 
            I express my thanks to all the staff members Dr. G. Chenthamarai, 
M. D., Dr. V. Deepa, M.D., Assistant Professors in Institute of Pharmacology, 
Madras Medical College, for their support throughout the project work. 
 I record my sincere thanks to Dr. Rama Devi, M.D., Director and Professor 
of Biochemistry for granting me permission and complete co-operation to do this 
study in the Institute of Biochemistry. 
            I would like to thank Mrs. G. Sasikala Devi, M.Sc., M. Phil., and Lab 
technicians in Institute of Pharmacology, Madras Medical College, for their support 
during the study. 
            I would like to extend my thanks to Dr. Dr. S. K. Seenivelan, M.D Special 
Veterinary Officer and Mr.Kandaswamy, Assistant of Animal Experimental House, 
Madras Medical College, for their continuous support in carrying out my dissertation. 
            I extend my heartfelt gratitude to Mr. S. Umasankar, B.E (Robotics) for him 
continuous support in carrying out my dissertation work. 
            I express my special thanks to Miss. A.Vigneswari for her help during the 
research work. 
            I have no words to express my joy in thanking the Almighty for giving me the 
fabulous group of friends in UG and PG and all other who are behind me supports 
my endeavors. 
            I honestly acknowledge the love; care and moral support extended to my 
parents and family members Mr. B. Sampath kumar, Miss. B. Jamuna, Mr. M. 
Rangappa, Mrs.M.Chinnamma, Mr. M. Jaisankar, Mrs.T.Bagyalakshmi for their 
constant encouragement and care all through my project work.  
         
. 
 
 
 
 
               
 
 
 
 
INDEX 
 
S.NO TITLE 
 
PAGE NO. 
1 INTRODUCTION 
 
1 
2 AIM AND OBJECTIVE 
 
11 
3 REVIEW OF LITERATURE 
 
12 
4              PLAN OF WORK 
 
24 
5 MATERIALS AND METHODS 
 
    5.1  PHYTOCHEMICAL SCREENING 
 
 5.2  IN VITRO ANTI DIABETIC STUDIES 
 
   5.3 ACUTE TOXICITY STUDY 
 
   5.4 INVIVO ANTIDIABETIC STUDIES 
25 
 
26 
 
28 
32 
 
33 
6 RESULTS 
 
39 
7 DICUSSION 
 
55 
8 CONCLUSION 
 
60 
9 REFERENCES 
 
 
10 APPENDIX  
 
ABBREVIATIONS 
 
DM                                    Diabetes Mellitus 
WHO                                 World Health Organization 
CF                                      Cassia fistula 
GOD-POD                        Glucose Oxidase-Peroxidase 
HMP                                  Hexose Mono Phosphate 
G6P                                    Glucose-6-Phosphate  
LDH                                   Lactate dehydrogenase 
G6PD                                 Glucose-6-phosphate dehydrogenase 
NADP                                Nicotinamide adenine dinucleotide phosphate 
GLP-1                                 Glucagon-likepeptide-1 
GI                                        Gastro intestinal 
SU                                       Sulfonyl Urea 
PPAR                                  Peroxisome Proliferator Activated receptor 
DPP-4                                  Dipeptidyl peptidase inhibitors 
STZ                                      Streptozotocin 
PPHG                                   Post-prandial hyperglycemia       
FDA                                     Food and Drug Administration 
Rtd                                      Retired 
CSIR                                   Council for Scientific and Industrial Research 
EDTA                                  Ethylene diamine tetra acetic acid        
ATP                                      Adenine Tri Phosphate   
HDL                                     High Density Lipoprotein 
ANOVA                               Analysis of variance 
SD                                         Standard Deviation 
GD                                        Glucose Diffusion 
p. o                                        Oral route  
b. w                                        Body weight 
rpm                                        Revolution per minute 
GDM                                     Gestational Diabetes Mellitus  
MODY                                  Maturity Onset Diabetes in Young  
NHC                                      Nonketotic Hyperosmolar Coma 
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1. INTRODUCTION 
                  The worldwide prevalence of diabetes have increased from around 60 
million in 1980 to about 118 million in 1995 and are set to increase to 220 million by 
the year 2010 (Amoes et al.,1997). According to the International Diabetes Federation 
(IDF), Diabetes affects at least 285 million people worldwide and that number will be 
expected to reach 471 million by the year 2035 
(1)
. 
            Traditional use of herbal medicine is the basis and integral part of various 
cultures, which was developed within an ethnic group before the developed and 
spread of modern science. Herbal drugs constitute a major part in all the traditional 
systems of medicine. These have made a great contribution in maintaining human 
health. A majority of the world’s population still rely on herbal medicines to meet its 
health needs. The practice continues today because of its biomedical benefits and its 
place in culture beliefs in many part of world.   
                India, china and several other nations have an ancient tradition of herbal 
remedies. The written records in Ayurveda, the ancient system of medicine in India, 
contain more than 800 herbal remedies. The Charaka Samhita and Sushruta Samhita 
are two treasure troves containing knowledge of plant based drugs and are even today, 
held in the highest esteemed the world over 
(2)
.   
            However, the name Diabetes was given by the two Roman physicians Celsius 
and Aretaeus in 1
st 
A.D in 1921. Banting and Best solved the problem of diabetes to a 
great extent by discovered Insulin as a therapeutic agent in Insulin Dependent 
Diabetes Mellitus. The first oral hypoglycemic agents suitable for clinical use were 
the sulfonylureas developed by Auguste Loubatieres in the year 
1940
(3)
.Conventionally, insulin dependent diabetes mellitus is treated with exogenous 
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insulin 
 
and non-insulin-dependent diabetes mellitus with synthetic oral hypoglycemic 
agents like sulphonylureas and biguanides
(4)
. However they fail to prevent 
complications of diabetes and also produce adverse health effects 
(5)
. Therefore, 
different medicinal systems are using the active plant constituents, which discovered 
as natural hypoglycemic medicine came from the virtue of traditional knowledge 
(6)
.
 
Asia’s large population and rapid economic development have made it an epicenter of 
the epidemic. Asian populations tend to develop diabetes at younger ages and lower 
BMI levels. Several factors contribute to accelerated
 
diabetic epidemic in Asians, 
including the “normal-weight metabolically obese” phenotype, high prevalence of 
smoking and heavy alcohol use; high intake of refined carbohydrates (e.g. white rice) 
and dramatically decreased physical activity levels. 
DIABETES MELLITUS 
          The word “Diabetes” is derived from “Greek” word “Diabainein” which 
means “to pass through”. It is characterized by an excess of glucose in blood and 
urine, hunger, thirst and gradual loss of weight. Insulin is a hormone which regulates 
the carbohydrates and triglyceride metabolism through its action at several sites and 
facilitates the entry of glucose into the cell. Insulin also stimulates the synthesis of 
glucokinase and moderates the degree of gluconeogenesis. In the diabetic patient, 
there is an aberration in the function of insulin.   
CLASSIFICATION OF DIABETES MELLITUS    
1) Type 1 Diabetes Mellitus
 (10)
 
              The hallmark also known as Insulin Dependent Diabetes Mellitus (IDDM). It 
is not associated with obesity and may be associated with acidosis or ketosis.                                                                                                                                              
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2) Type 2 Diabetes Mellitus 
             Type 2 diabetes is characterized by tissue resistance to the action of insulin 
combined with a relative deficiency in insulin secretion. It is also known as adult 
onset diabetes or Non-Insulin Dependent Diabetes Mellitus (NIDDM). 
 3) Gestational Diabetes Mellitus (GDM) 
(11)
 
           It is defined as any abnormality in glucose levels noted for the first time 
during pregnancy and resolves after delivery.  
4) Maturity Onset Diabetes in Young (MODY) 
           MODY   is defined as hyperglycemia diagnosed before the age of 25 years 
and treatable for more than 5 year without insulin.  
5) Genetics
 (12)
 
            Susceptibility to both IDDM and NIDDM is determined to a substantial 
extent by genetic factor.  
SIGNS AND SYMPTOMS OF DIABETES METTILUS 
(13) 
                These are mainly due to hyperglycemia with decreased utilization of 
glucose by cells: as a result, there is an extracellular glucose excess and intracellular 
glucose deficiency, a situation called starvation in the midst of plenty. 
1. Hyperglycemia (raised blood glucose), it predisposes to infection like boils 
and urinary tract infection. 
2. Glycosuria (presence of glucose in the urine) 
3. Polyurea (excess urine production)  
4. Dehydration  
5. Polydipsia (increase thirst) is a result of the dehydration that results from the 
osmotic dieresis. 
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6. Polyphagia (excess eating) low glucose utilization by glucose cells of 
ventromedial nucleus in hypothalamus (satiety center) result in no inhibition 
of lateral nucleus in hypothalamus (feeding center) which eventually produces 
increased hunger. 
7. Loss of weigh. 
8. Ketonuria. 
9. Poor resistance to infections due to protein depletion. 
10.   Hyperlipedemia (abnormally high serum lipid levels). Insulin deficiency 
decreases LDL receptor availability, which decreases serum cholesterol 
clearance. This decreased clearance produces hypercholesterolemia or high 
blood chlosterol. 
11.  Electrolyte depletion. 
COMPLICATIONS OF DIABETES MELLITUS 
(15)
 
 Diabetic ketoacidosis 
 Nonketotic hyperosmolar coma (NHC) 
 Insulin shock 
LONG TERM SEQUELAE OF DM 
            Long-term problems associated with DM include neuropathies, 
nephropathies, microangiopathies, microangiopathies and retinopathies.               
CHEMICAL AGENTS CAPABLE OF INDUCING DIABETES 
(16) 
 Alloxan 
 Streptozotocin 
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Alloxan Induced Diabetes 
            Alloxan, a cyclic urea analogue, was the first agent producing permanent 
diabetes in animals. It is a highly reactive molecule readily reduced to diuleric acid, 
then auto-oxidized back to Alloxan resulting in the production of free radicals. These 
free radicals damage the DNA of β-cells and cause cell death. Second mechanism 
proposed for Alloxan is its ability to react with protein SH groups, especially the 
membrane proteins like glucokinase on the β-cells, finally resulting in cell necrosis. 
Drawbacks   
 High mortality in rats. 
 Causes ketosis due to free fatty acid generation. 
 Diabetes induced is reversible. 
 Some species like guinea pigs are resistant to its diabetogenic action. 
Streptozotocin Induced Diabetes 
               STZ [2-deoxy-2-(3-methyl-3-nitrosourea) 1-D-glucopyranose] is a broad-
spectrum antibiotic, which is produced from streptomyces achromogens. STZ causes 
β-cell damage by process of methylation, free radical generation and nitric oxide 
production. 
Advantages   
STZ has almost completely replaced Alloxan for inducing diabetes because of 
 Greater selectivity towards β-cells 
 Lower mortality rate  
 Longer or irreversible diabetes induction. 
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Disadvantage 
                Guinea pigs and rabbits are resistant to its diabetogenic action. 
OTHER DIABETES MELLITUS INDUCED MODELS 
1. Hormone-Induced Diabetes Mellitus 
             Dexomethasone, a long acting glucocorticoid, is used to produce NIDDM at 
a dose of 2-5mg/kg, i.p, twice daily over a number of days in rats. 
2. Insulin Antibodies-Induced Diabetes 
             Giving bovine insulin along with CFA to guinea pigs produces anti-insulin 
antibodies.  
3. Viral Agents –Induced Diabetes     
                Viruses are thought to be one of the etiologic agents for IDDM. Viruses 
may produce diabetes mellitus by 
 Infecting and destroying of β-cells in pancreas. 
 A less infecting or cytologic variant producing a comparable damage by 
eliciting immune auto reactivity to the β-cells. 
 Viruses producing systemic effect, not directly affecting the β-cells. 
4. Surgically Induced Diabetes 
                Surgical removal of all or part of the pancreas can induce Diabetes Mellitus. 
In partial pancreactomy more than 90% of the organ must be removed to produce 
diabetes.  
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MANAGEMENT OF DIABETES MELLITUS 
(17) 
              The goals of treatment for diabetes are to reduced and control blood glucose 
levels, relive the symptoms of the disease and prevent complications. Intensive 
treatment and careful control of blood glucose levels can reduce the risk of 
complications of diabetes 
(18)
.
 
I.NON PHARMACOLOGICAL INTERVENTIONS 
              The major environmental factors that increase the risk of type 2 diabetes, 
presumably in the setting of genetic risk are nutrition and sedentary lifestyle with 
consequent over weight and obesity. Medical nutrition therapy (i.e. diet) and exercise 
are important aspects of non-pharmacologic treatment for diabetes. Weight loss is a 
vital part of treatment for type 2 diabetes because it can help improve the sensitivity 
of cells to insulin and the uptake of glucose by cells. 
II. PHARMACOLOGICAL INTERVENTIONS 
A) Injectable anti-diabetic agents 
(19)
 
    1) Insulin 
                 All patients with type 2 diabetes require insulin injections. Patients with 
type 2 disease who have multiple symptoms of hyperglycemia are pregnant or have 
ketosis also should use insulin injections. Currently, insulin used for treatment is 
derived from beef and pork pancreas as well as recombinant (human) DNA 
technology. 
      2) Glucagon like peptide-1 (glp-1) agonist 
                 The glucogan like peptide-1 (GLP-1) is an important incretin that is 
released from gut in response to oral glucose. It is difficult to use clinically because of 
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rapid degradation by the enzyme dipeptidyl peptidase-4 and it is injected 
subcutaneously twice daily one hour before meals acts for 6-10 hours. 
      3) Amylin agonists 
                 This synthetic amylin (a polypeptide produced by pancreatic β-cells which 
reduces glucagon secretion from  -cells and delays gastric emptying) analogue 
attenuates postprandial hyperglycemia when injected subcutaneously just before meal 
and exerts a centrally mediated anorectic action. 
B) Oral hypoglycemic drugs: 
                 Oral hypoglycemic drugs include sulfonyl ureas, biguanides, meglitinide/ 
phenylalanine analogue, thiazolidinediones,  -glucosidase inhibitors, dipeptidyl 
peptidase inhibitors and incretin mimetics. 
         1) Sulfonyl ureas [e.g. Glibenclamide, Glimepride, Glipizide, etc.]   
         2).Biguanides [e.g. Metformin] 
         3) Meglitinide / D-Phenylalanine analogues 
             [E.g. Repaglinide, Nateglinide] 
         4) Thiazolidinediones [e.g. Rosiglitazone, Pioglitazone] 
         5)     Glucosidase Inhibitors (e.g. Acarbose, Miglitol, Voglibose) 
         6) Dipeptidyl Peptidase Inhibitors: (e.g. Sitagliptin) 
         7) Incretin Mimetics: (e.g.Liraglutide)  
             All oral antidiabetic agents have side effects. Sulfonylureas are associated 
with weight gain and hypoglycemia. The major side effect of  -glucosidase 
inhibitors is flatulence. The major problems with the thiazolidinediones are those 
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of fluid retention, dilutional anemia. Metformin increased risk of gastrointestinal 
problems 
(20)
. In India it is proving to be a major health problem, especially in the 
urban areas. Though there are various approaches to reduce the ill effects of 
diabetes and its secondary complication, herbal formulations are preferred due to 
lesser side effect and low cost 
(7)
.   
            More than 400 different plants and plants extracts have been described as 
reputedly beneficial for the diabetic patient. Most of these plants have been claimed to 
possess hypoglycemic properties but most claims are anecdotal and few have received 
adequate medical or scientific evaluation. Those that have been evaluated may be 
grouped into three categories: 
1. Plants from which a reputedly hypoglycemic compound or partially 
characterized hypoglycemic fraction has been prepared. 
2. Plants reported to exert a hypoglycemic effect, but the nature of the 
active principle is unestabilised. 
3. Plants that reputedly exert a hypoglycemic effect, but the scientific 
evidence is equivocal. These categories exclude the numerous 
traditional plants for which an independent scientific or medical has 
not been published. 
         Cassia fistula L.  found throughout the tropical parts of India. It is said to be 
useful in the treatment of hematemesis, pruritis, intestinal disorder, leucoderma, 
diabetes, antipyretic, analgesic & laxative 
(8)
. It has various pharmacological activities 
like antifungal, antioxidant, antimicrobial, anti-inflammatory, anti-tumor, 
hypoglycemic activities 
(9)
. However, till date there has been no investigation 
supporting the anti-diabetic properties of root of this plant. Hence, this study has been 
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taken with an aim to evaluate the in vitro and in vivo anti-diabetic potential of root 
bark of Cassia fistula L. on Streptozotocin induced diabetic model.   
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2. AIM AND OBJECTIVES 
 
 Successive extraction of root bark of Cassia fistula L. by Soxhlet extraction 
apparatus using various solvents n-hexane, ethyl acetate and ethanol. 
 
 Phytochemical evaluation of root bark of ethanolic extract of Cassia fistula L. 
 
 To determine the inhibition of alpha-amylase enzyme and glucose diffusion 
property of the prepared extract of the Cassia fistula L. using dialysis tube and 
GOD-POD kit.  
 
 To evaluate the safety of the effective extract of Cassia fistula L. by acute 
toxicity study in Wistar rats. 
 
 To investigate the in vivo anti diabetic effect of active extract of Cassia fistula 
L. on Streptozotocin induced diabetic wistar rats. 
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3. REVIEW OF LITERATURE 
Review of literature related to antidiabetic activity 
Kumari et al., 1995 
(21)
 
                Allium cepa (Onion) is an essential plant cultivated throughout India, 
belongs to the family Liliaceae. Various parts such as seedling, callus, bulb etc., are 
known to possess anti-diabetic activity. Investigation revealed the presence of sulfur 
containing amino acid, which when administered orally to Alloxan induced diabetic 
rats (200mg/kg for 45 days) significantly controlled blood glucose and lipid in serum 
and normalized the activity of liver Hexokinase, glucose-6-phosphatase and HMG-
CoA reductase. The effect was in accordance with that of Glibenclamide and Insulin.  
Zacharias et al., 1980 
(22)
 
                Allium sativum (Garlic) belongs to the family of Alliaceae. Aqueous extract 
of garlic increased hepatic glycogen and free amino acid content when given orally to 
sucrose fed rabbits (10ml/kg/day). Garlic is known to decreased fasting blood sugar, 
triglyceride level in serum liver and aorta and protein levels when compared with 
sucrose controls. 
                Faiyaz Ahmed et al., 2008 
(23) 
was evaluated the antihyperglycemic activity 
of the bark powder and aqueous extract of Ficus glomerata (Moraceae) in STZ 
induced diabetic rats. Oral administration of Ficus glomerata bark powder (FGB) and 
Ficus glomerata aqueous extract (FGAE) at 500mg/kg caused 21% and 52% 
reduction in fasting blood glucose respectively and also decreased glycosuria 
significantly. Histology of pancreas suggested normalized of islets of langerhans and 
β-cells with respect to their number and cellular architecture. The results suggested 
that the bark of Ficus glomerata has significant anti-hyperglycemic activity in 
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experimental animals and has potential to be used as an adjunct in the management of 
diabetes mellitus. 
M.R.M. Rafiullah et al., 2006 
(24)
 
               The effect of aqueous extract of Syzygium cumini Linn. Gymnema sylvestre 
(Retz) Schult and Portulaca olearcea Linn. were investigated in fasting normal and 
Streptozotocin (STZ) induced diabetic rats. The effects of extract on oral glucose 
tolerance in normal fasting rats were also studied. The aqueous extract of S.cumini 
(200mg/kg) and G.sylvestre (200mg/kg) decreased the blood glucose in normal rats 
significantly at 2 and 4 hours of extracts administration (p<0.05, p<0.001). The 
S.cumini and G.sylvestre extracts decreased the increase of glucose levels 
significantly (p<0.05) at 90 and 180 minutes after the glucose load in glucose 
tolerance test. In STZ induced diabetic animals, the aqueous extracts of S.cumini and 
G.sylvestre decreased the blood glucose significantly (p<0.05) at 4 hours. The 
aqueous extract of P.olearancea did not show any hypoglycemic activity. 
Rajasekaran et al., 2005 
(25)
 
               Aloe barbabensis commonly called as Aloe vera is a medicinal herb; belongs 
to the family Liliaceae; Leaf gel, Leaf pulp and dried sap are known to possess 
antidiabetic and antioxidant activity by oral administration of ethanolic extract at a 
concentration of 300mg/kg body weight for 21 days. It was proved more effective in 
controlling oxidative stress found in diabetes. 
 Anderson and Polansky, 2002 
(26)
 
             Camellia sinensis belongs to the family Theaceae, commonly known as Tea. 
The blood glucose level lowering activity has been extensively investigated. 
Antihyperglycemic activity of hot water extract of green tea in STZ induced diabetic 
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rats were studied by Gomes et al.(1995), these findings have been supported by 
Anderson and Polansky (2002). Tea polyphenols possess antioxidant capacity; have 
also been reported to inhibit  -amylase. 
 Pradeep Goyal et al., 2015 
(27)
 
                Borassus flabellifer is used extensively in the indigenous system of 
medicine as an antidiabetic agent. The investigation focus on the antihyperglycemic 
and antihyperlipidemic property of acetone insoluble ethanolic fraction of Borassus 
flabellifer extract on streptozotocin induced diabetic rats. The diabetic induced 
animals were fed with  extracts of Borassus flabellifer at the increasing  doses  of 
150mg, 300mg, 600mg/kg body weight administrated animals revealed a significant 
(P<0.01) decreased blood glucose level and higher reduction in hyperlipedemia when 
compared to the diabetic controls rats(P<0.01). The histopathological studies of the 
endocrine region of pancreas of diabetic animals revealed that shrinkage of β-cells of 
islets of langerhans. The extracts treated animal revealed restoration of β-cells. The 
restoration of β cells was evident at higher dose level i.e. 600mg/kg body weight 
extracts fed group. 
Review of literature related to Cassia fistula Linn. 
ANTIOXIDANT ACTIVITY 
    Manonmani G et al., 2005 
(28)
 
                Aqueous extract of Cassia fistula (Linn) flowers (ACF) was screened for its 
antioxidant effect in alloxan induced diabetic rats. An appreciable decreased in 
peroxidation products viz thiobarbituric acid reactive substances, conjugated dienes, 
hydro peroxides was observed in heart tissues of ACF treated diabetic rats. The 
decreased activities of key antioxidants enzyme such as superoxide dismutase, 
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catalase, glutathione peroxidase, glutathione reductase and glutathione in diabetic rats 
were brought back to near normal range upon ACF treatment. These results suggested 
that ACF has got promising antioxidative activity in alloxan induced diabetic rats.  
Raju Ilavarasan et al., 2005 
(29)
 
               Antiinflammatory and antioxidant activities of the aqueous (CFA) and 
methanolic extracts (CFM) of the Cassia fistula Linn. bark were assayed in wistar 
albino rats. The extracts were found to possessed significant anti-inflammatory effect 
in both acute and chronic models. Cassia fistula bark extracts showed significant 
radical scavenging by inhibiting lipid peroxidation initiated by CCl4 and FeSO4 in rat 
liver and kidney homogenates. Further, the acute toxicity study with the extracts 
showed no sign of toxicity up to a dose level of 2000mg/ p.o. Thus it could be 
concluded that Cassia fistula bark extracts possessed significant anti-inflammatory 
and antioxidant properties.     
ANTIFUNGAL ACTIVITY 
Souwalak phongpaichit et al., 2004 
(30)
 
               Crude methanol extracts from leaves of Cassia alata, Cassia fistula and 
Cassia tora were investigated for their antifungal activities on three pathogenic fungi 
(Microsporum gypseum, Trichophyton rubrum and M.gypseum with the 50% 
inhibition concentration (IC50) of hyphal growth at 0.5 and 0.8mg/ml, respectively, 
whereas the extract of C. fistula was the most potent inhibitor of P. marneffei with the 
IC50 of 0.9mg/ml.  
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ANTIPARASITIC ACTIVITY 
Patricia sartorelli et al., 2008 
(31)
 
              The fractionation through bioguided antileishmanial activity of the 
dichloromethane extract of Cassia fistula fruits led to the isolation of the active 
isoflavone biochanin A, identified by spectroscopic methods. This compound showed 
50% effective concentration (EC50) value of 18.96µg/mL against promastigotes of 
Leishmania (L.) chagasi. The cytotoxicity of this substance against peritoneal 
macrophages resulted in an EC50 value of 42.58µg/ml. Additionally biochanin A 
presented an antitrypanosomacruzi activity, resulting in an EC50 value of 18.32µg/ml 
more effectiveness than benzimidazole. These results contribute with novel 
antiprotozoal compounds for future drug design studies. 
CNS ACTIVITY 
U.K.mazumder et al., 1998 
(32) 
             The methanolic extract of the seed of Cassia fistula was tested for different 
pharmacological actions in mice. The methanolic extract (ME) of the seed 
significantly potentiated the sedative actions of sodium pentobarbitone, diazepam, 
meprobamate and chlorpromazine. A depressant action of ME was also evident from 
the behavioural studies on mice. 
HYPOLIPIDEMIC ACTIVITY 
Gupta et al., 2009 
(33) 
            The effect of 50% ethanolic extract of Cassia fistula Linn. legume was 
assessed on serum lipid metabolism in cholesterol fed rats. Oral feeding of cholesterol 
(500mg/kg b.w/day) dissolved in coconut oil (0.5ml/day) for 90 days caused a 
significant (p<0.001) elevation in total and LDL cholesterol, triglycerides and 
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phospholipids in serum of rats. Administration of C. fistula legume extract at the 
doses 100, 250, 500mg/kg b.w/day along with cholesterol significantly prevented the 
rise in the serum total and LDL cholesterol, triglycerides and phospholipids in a dose 
dependent manner. The ratio of HDL cholesterol /total cholesterol ratio were elevated 
in serum of C. fistula extract treated groups as compared to cholesterol alone fed 
control rats.    
LAXATIVE AND ANTIMICROBIAL ACTIVITY 
KA Abo et al., 1999 
(34) 
             Colorimetric estimation of anthroquinones content, antimicrobial and laxative 
effects of leaves and pods of Cassia fistula Linn, C. specatabilis DC and C. 
podocarpa Guill are described because of the popular uses of these species by 
herbalists in Ibadan. The pods of the Cassia species exhibited potent antifungal 
activity than the leaf samples. Pods of C. fistula showed significant antibacterial 
activity when compared to that of ampicillin. This study justifies the use of the cassia 
species in traditional medicine.  
ANTIULCER ACTIVITY 
S. Karthikeyan et al., 2010 
(35)
 
             The ethanolic leaf extract (ELE) of cassia fistula Linn was evaluated for 
antiulcer activity against pylorus ligation-induced gastric ulcer. Ranitidine (30mg/kg 
b.w) and ELE at doses of 250, 500 and 750mg/kg/b.w.were administered orally in 
different groups of rats (n=6), 1h prio to pyloric ligation. ELE pre-treatment 
significantly attenuated the fall in status of sialic acid and fucose accompanied by an 
increase in hexose, hexosamine, total non-amino polysaccharide, total carbohydrate 
and C: P ratio in the gastric juice of pylorus ligated rats and this effect could be due to 
                                                                              Review of literature 
 
Institute of Pharmacology, MMC. Page 18 
 
protective of the mucosal barrier system. This protective ability of ELE against 
pylorus ligation-induced gastric ulcer could be attributed the radical scavenging and 
antioxidant properties. Higher doses of ELE (750mg/kg b.w) produced maximum 
antiulcer activity comparable to ranitidine treatment.  
ANTI-ITCHING ACTIVITY 
Manisha Talekar et al., 2015 
(36)
 
              Leaves of Cassia fistula Linn is known as a rich source of tannins, flavonoids 
and glycosides. Might be medicinally important and/or nutritionally valuable and used 
in many skin diseases. The therapeutic effect of paste of leaves of Cassia fistula Linn 
in management of eczema was evaluated. Total 30 patients of eczema fulfilling the 
inclusion criteria were randomly selected from the O.P.D and I.P.D. of national 
institute of Ayurveda, Jaipur. The informed consent from each patient was taken and 
treated with paste of leaves of Cassia fistula Linn. for 4 weeks. Leaves of Cassis 
fistula Linn was found to be more effective to control discoloration, itching, oozing, 
pain, burning, lines/thickening of skin and eruption.   
PROTEASE-INHIBITORY ACTIVITY 
 Ratna wijaya et al., 2000 
(37) 
                   A novel trypsin inhibitor was extracted from the seeds of Cassia fistula by a 
process successively involving soaking seeds in water, extraction of seeds in methanol 
and extraction of the cell wall material at high ionic strength. The protease inhibitor 
(PI) was subsequently purified by chromatography on carboxy methylcellulose, gel 
filtration and reversed phase HPLC (RP-HPLC). The C. fistula seed PI is homologous 
to the family of plant defensins (Ý-thionins), which have four disulfide linkages at 
highly conserved locations. The C. fistula PI inhibits trypsin (IC50 2 µM) and is the 
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first known example of a plant defensins with protease inhibitor activity, suggesting a 
possible additional function for some members of this class of plant defensive 
proteins. 
HEPATOPROTECTIVE ACTIVITY 
Sagar dawada et al., 2012 
(38) 
              The protective effects of the alcoholic extract of Cassia fistula root against 
CCl4 induced hepatic failure in male albino rats (Wistar strain) were investigated. The 
administration of alcoholic root extract (200mg/kg and  100mg/kg of body weight) for 
7 days, elicited protective action since the elevated levels of marker enzymes (SGOT, 
SGPT, ALP) of liver functions were found to be decreasing progressively in a dose 
dependent manner. The results found in alcoholic extract 200mg/kg treated rat were 
quite promising and were comparable with a standard drug silymarin. In the alcoholic 
extract 200mg/kg treated rat group all the marker enzymes were analyzed to be 
decreasing significantly. The alcoholic root extract of Cassia fistula root (200mg/kg 
and 100mg/kg) was found to be possessed dose dependent, significant protective 
activity against CCl4 induced hepatotoxicity. 
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PLANT PROFILE 
(39)
 
 
Name       :  Cassia fistula L 
 Synonym :  Bactyrilobium fistula Willd. 
                     Cassia bonplandiana DC. 
Taxonomy 
              Kingdom :  plantae 
              Class        :  Magnoliopsida 
              Subclass  :  Rosidae 
              Order      :  Fabales 
              Genus      :  Cassia 
              Family     :  Caesalpiniaceae 
Vernacular name 
              English     :  Indian Laburnum, Golden shower  
              Tamil        :  Sarakonrai, Sarak konnai 
              Sanskrit    :  Aragvadha, Krtamala 
              Telugu      :  Rela 
              Malayalam:  Konna, Kritamalam                        
     Distribution    
              Subtropical, common in tropical India and Pakistan, Myanmar, Thailand and     
Sri Lanka. 
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Description 
  Plant 
              The tree is a medium sized tree, growing to 10 – 20m (33 -66ft) tall with fast 
growth. 
Leaves 
              The leaves are deciduous, 15 – 60cm long and pinnate with three to eight 
pairs of leaflets, each leaflet 7 – 21cm long and 4 – 9cm broad. 
Flowers 
              The flowers are produced in pendulous racemes 20 -40cm long, each flower 
4- 7cm diameter with five yellow petals of equal size and shape. 
Fruits 
              The fruit is a legume, 30 -60cm long and 1.5- 2.5cm broad, with a pungent 
odor and containing several seeds. 
Chemical composition 
              Glycosides, cardiac glycosides, 
              Anthroquinones, flavonoids 
Parts used  
               Roots, leaves, fruits, barks are used. 
Properties and uses 
 The fruit pulp is considered a purgative. 
 Roots are used as a hepatoprotective and antibacterial activity (38). 
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 Leaves and seed have various pharmacological activities like anti fungal, 
antioxidant, antimicrobial, anti-inflammatory, anti-tumor, hypoglycemic 
activities 
(40)
. 
 It is used in the treatment of hematemesis, pruritis, intestinal disorder, 
leucoderma, diabetes, antipyretic, analgesic & laxative 
(8)
. 
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Cassia fistula L. - WHOLE PLANT 
 
 
Cassia fistula L. -root bark 
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4. PLAN OF WORK 
 
 
                                      
           Root bark of Cassia fistula L. 
Authentication of plant material 
       Collection and processing of plant 
           Extraction of root of Cassia fistula L. using various solutions (n-hexane, ethyl acetate and ethanol) 
Pharmacological studies Phytochemical studies 
             In vivo 
antidiabetic studies 
study 
            In vitro antidiabetic studies 
1. Inhibition of  -amylase enzyme 
2. Glucose diffusion assay 
 Blood glucose and body 
weight changes. 
 Biochemical parameters. 
 Histopathological studies. 
      Acute toxicity study 
   (OECD Guidelines 423) 
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5. MATERIALS AND METHODS 
 
PLANT COLLECTION AND IDENTIFICATION 
         Dried entire plant of Cassia fistula L. was collected from forest around 
Komaneri, Tirunelveli District, Tamil Nadu (India), in the month of July. It was 
authenticated by prof. V. Chelladurai, Research officer-Botany (Scientist-C) (Rtd), 
Central Council for Research in Ayurveda & Siddha, Govt. of India.   
PREPARATION OF PLANT EXTRACTION 
            The plant was shade dried at room temperature and was subjected to size 
reduction to a coarse power by using dry grinder. 50grams of this coarse power was 
packed into Soxhlet apparatus and was subjected to extraction sequentially with 
500ml of n-hexane, ethyl acetate and ethanol. The extraction was continued until the 
colour of the solvent in the siphon tube became colorless. Extraction procedure was 
carried out in Institute of Pharmacology, Madras Medical College, Chennai. Extracts 
of ethyl acetate and ethanol were subjected to evaporation by using Rotary evaporator 
at 60ºC. 
VARIOUS 
EXTRACT 
CONTENT(g) PERCENTAGE 
YIELD 
n-Hexane 5 10 
Ethyl acetate 17 34 
Ethanol 24 48 
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5.1 QUALITATIVE PHYTOCHEMICAL STUDIES 
(41-43) 
            The freshly prepared extracts of n-hexane, ethyl acetate and ethanol were 
subjected to phytochemical screening for the presence or absence of active 
phytochemical constituents by following methods. 
Test for Alkaloids 
            Crude extract was treated with few drops of dilute hydrochloric acid and 
filtered. The filtrate was tested with various alkaloid reagents such as  
Mayer’s reagent               :   Cream precipitate 
Dragendroff’s reagent     :    Orange brown precipitate 
Wagner’s reagent             :     Reddish brown precipitate 
Test for Steroids 
            Salkowskis test: Crude extract was mixed with 2ml of chloroform. Then 2ml 
of conc. Sulphuric acid was added carefully and shaken gently. Appearance of reddish 
brown colour ring indicated the presence of steroids. 
Test for Flavonoids 
            Lead acetate test: Crude extract was treated with few drops of lead acetate 
solution. Appearances of yellow colour precipitate indicate the presence of 
flavonoids. 
            Alkaline reagent test: Crude extract was treated with few drops of sodium 
hydroxide solution. Formation of intense yellow color, which becomes colorless on 
addition of dilute acid, indicates the presence of flavonoids. 
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            Shinoda test: Crude extract was treated with 5ml of 95% ethanol, few drops 
of concentrated hydrochloric acid and 5grams of magnesium turnings, appearance of 
pink colour indicated the presence of steroids. 
Test for Phenols and Tannins 
            Crude extract was mixed with 2ml of 2% solution of ferric chloride. 
Appearance of violet   colour indicates the presence of phenolic compounds and 
tannins. 
            Crude extracts was dissolved in water and treated with 10% of lead acetate 
solution, appearance of white precipitate indicate the presence of tannins and phenolic 
compounds. 
Test for Saponins 
            Foam test: A small amount of extract was extracted with petroleum ether. To 
the insoluble residue left after extraction, a few ml of water was added and shaken 
vigorously for 15minutes and was observed for the formation of honeycomb froth that 
persisted for at least 30minutes. 
Test for Terpenoids 
            Noller’s test: The extract was warmed with tin and thionyl chloride. Pink 
coloration indicates the presence of terpenoids. 
Test for Glycosides: 
            Borntrager’s test: A small amount of extract was hydrolyzed with 
hydrochloric acid for few hours on a water bath and the hydrolysate was extracted 
with benzene. The benzene layer was treated with dilute solution and was observed 
for formation of reddish pink colour. 
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            Legal test: The extract was dissolved in pyridine and was made alkaline with 
few drops of 10% sodium hydroxide and then freshly prepared sodium nitroprusside 
was added and observed for the formation of blue colour. 
            Libermann-burchard test: 1mg of the extract was dissolved in few drops of 
chloroform, 3ml of glacial acetic acid. Warmed, cooled under tap water and drops of 
concentrated sulphuric acid was added along the side of the test tube, formation of 
bluish green colour indicates the presence of steroids. 
Test for Carbohydrate 
            A small quantity of various extracts were dissolved separately in 5ml of 
distilled water and filtered. The filters were subjected for the following tests: 
            Molisch test: The filtrate was treated with few drops of alpha-naphthol. Then 
about 1ml of concentrated H2SO4 was added along the sides of the test tube. Violet 
colour ring formation at the interface indicates the presence of carbohydrates.  
DRUGS AND CHEMICALS 
          Sodium chloride, D-glucose, Ethanol, Sodium citrate tribasic-dihydrate, Citric 
acid monohydrate, Streptozotocin, Glibenclamide. 
5.2 IN VITRO ANTIDIABETIC EVALUATION   
Physical Method  
            Ability of the plant materials to retards the movement of glucose from the 
intestine into the blood was evaluated by physical methods in vitro. The following are 
the convenient models for assessing the materials which affect the absorption of 
glucose in vitro. 
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A. Glucose Diffusion Assay 
(44)
   
          Plant extracts were mixed with glucose and placed in the sealed dialysis 
membrane and kept in the orbit shaker bath at 37ºC, at 150rpm. The movement of 
glucose across the membrane into the external solution was measured at periodic 
intervals using commercial GOD-POD kit. 
Requirements 
 Dialysis membrane 
 0.15M sodium chloride solution 
 D- Glucose  (25Mm in sodium chloride solution) 
 Orbit shaker 
 GOD - POD kit 
Procedure 
           Dialysis membrane containing 2ml of 25mM glucose solution was mixed with 
1ml of different plants extracts  and was placed in the centrifuge tube containing 45ml 
0.15M NaCl and then kept in orbit shaker bath at 37ºC at 150rpm. The movement of 
glucose into the external solution was monitored at set of time intervals using GOD-
POD kit. Glucose concentration in the external solution was expected as mg/dl/hr. 
B. Inhibition of Alpha-Amylase Enzyme 
(45)
 
Requirements 
 1%   Amylase 
 1% Starch 
 Iodine reagent 
 0.02M Sodium Phosphate buffer and HCl 
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Procedure 
              A starch solution (1%) was obtained by stirring 0.1g of potato starch in 
100ml of 16Mm of sodium acetate buffer. The enzyme solution was prepared by 
mixing 27.5mg of alpha-amylase in 100ml of distilled water. The colorimetric 
reagents is prepared by mixing sodium potassium tartarate solution and 3, 5 di nitro 
salicylic acid solution 96Mm. Both control and plant extracts (200, 400, 600, 800, 
1000 and 1200µg/ml) were added with starch solution and left to react with alpha-
amylase solution under alkaline conditions at 25ºC. The reaction was measured over 3 
minutes. The generation of maltose was quantified by the reduction of 3, 5 dinitro 
salicylic acid to 3-amino-5-nitro salicylic acid. This reaction is detectable at 540nm. 
Calculation 
           Percentage inhibition (I %) =   (Ac- As) / Ac   100 
  Where Ac is the absorbance of the control and As is the absorbance of the sample. 
 
IN VIVO ANTI DIABETIC STUDIES 
(46) 
 
Experimental animals 
             The present study was conducted after obtaining approval from the 
Institutional Animal Ethics Committee and this protocol met the requirements of 
national guidelines of CPCSEA (PROPOSAL NO: 08/43/CPCSEA dated: 
10/08/2015). The wistar rats (150-200 gm) used for this study were procured from 
Animal house, Madras Medical College, Chennai, India. 
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Quarantine and Acclimatization 
             Quarantine is the separation of newly received animals from those already in 
the facility until the health and possibly the microbial status of the newly received 
animals have been determined. The newly procured Wistar rats were quarantined for 
the period of 10 days to minimize the chance of introduction of pathogens into 
established animals and allowed to develop the psychological, physiological and 
nutritional stabilization before their use. 
Housing 
              The animals were housed in well ventilated animal house which was 
maintained at a constant temperature and relative humidity of 55 to 60%. The animals 
were housed in spacious polypropylene cages and paddy husk was utilized as bedding 
material. 
Diet and water 
              The animals were maintained on standard pellet diet and purified water. The 
animals were provided with food and water ad libitum except during fasting. The bed 
material was changed twice a week. 
Animal identification 
              All animal cages used in the study had a proper identification i.e., labels. 
Each animal in the cage was marked either on head or body or tail with picric acid for 
their appropriate identification. 
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TOXICITY STUDIES 
              Acute toxicity was designed as per the OECD guidelines (423). 
(38),
 
(47) 
 
5.3 ACUTE TOXICITY STUDY 
Principles and purpose 
              The main purpose of acute toxicity is to evaluate the degree of toxicity in a 
quantitative and qualitative manner with the purpose of comparing it with other drug 
substances (e.g. other drug candidates for the same indication). 
Experimental Animals 
             Three healthy adult wistar albino rats weighing between 150-250g were 
selected for the study. For all the three animals food, but not water was withheld 
overnight prior to dosing. 
Selection of dose levels and administration of doses 
             Being a traditional herbal medicine, the mortality was unlikely at the highest 
starting dose level (2000mg/kg/b.w). Hence a limit test at one dose level of 
2000mg/kg/b.w was conducted in all the three animals as per the OECD guidelines 
(423). 
 
5.4 INVIVO ANTIDIABETIC EVALUATION 
           The antidiabetic activity of Cassia fistula Linn. was evaluated in diabetic 
Wistar rats. Diabetes was induced by intra-peritoneal injection of Streptozotocin 
45mg/kg/b.w for 7 days. The antidiabetic effect of plant extract was compared with 
standard drug Glibenclamide. 
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Preparation of Streptozotocin Solution 
             Preparation of 0.1M citrate buffer solution pH 4.5. An accurately weighed 
quantity of trisodium citrate dehydrate (2.941g) is dissolved in 100ml distilled water 
and accurately weighed quantity of citric acid (2.101g) is dissolved in 100ml distilled 
water. Mix 44.5ml of 0.1M citric acid monohydrate and 55.5ml of 0.1M trisodium 
citrate dehydrate (pH 4.5).    
Induction of diabetes in rats 
              After 10 days of acclimatization, the rats were subjected to overnight fasting. 
Diabetes was induced by intraperitoneal injection of Streptozotocin, freshly dissolved 
in citrate buffer pH 4.5. The animals were allowed to drink water 5% glucose solution 
overnight to overcome the drug induced hypoglycemic due to massive release of 
insulin from β-cells. After the induction, on 3rd day the blood glucose levels were 
measured and the animals with a blood concentration of more than 250mg/dl were 
considered as diabetic and taken for the experiment. Administration of the plant 
extract was started on the 4
th
 day after streptozotocin injection and this was 
considered as the 1
st
 day of treatment, which was continued for 21 days. 
 Experimental design 
             The fasting glucose and body weight of all animals were recorded at the 
beginning of the study. The blood glucose was checked by one touch glucometer 
throughout the study, in the experiments, 30 rats were divided into 5 groups of six rats 
each. 
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Group 1 Normal control rats, received distilled water. 
Group 2 Streptozotocin induced diabetic rats received distilled water and served as 
diabetic control for   21 days. 
Group 3 STZ induced diabetic rats received standard drug Glibenclamide    
(5mg/kg/BW, p.o)   for 21 days. 
Group 4 STZ induced diabetic rats received the plant extract (200 mg/kg/BW, p.o) 
for 21 days. 
Group 5 STZ induced diabetic rats received the plant extract (400 mg/kg/BW, p.o) 
for 21 days. 
 
              For all rats, body weight was measured before and after the induction of 
diabetes. Blood glucose level was measured on 1, 7, 14 and 21
st
 day throughout the 
study period by tail tip cutting method. At the end of the experiment, sufficient blood 
was collected by retro-orbital bleeding from all the animals under mild anaesthesia for 
estimation of haematological and biochemical parameters. 
Biochemical parameters 
              The blood samples were centrifuged at 3000rpm for 5 minutes using REMI 
(412LIG) cooling centrifuge. The serum was kept at -80ºC until analyzed. Levels of 
total cholesterol, triglycerides (TGL), high density lipoprotein (HDL) were 
determined with an automatic analytical instrument (Hitachi 911, Japan). 
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A) ESTIMATION OF LIPID PROFILE 
(48)
 
Principle 
              The cholesterol esters and cholesterol present in the sample are acted upon by 
Cholesterol Esterase to release Cholesterol and Fatty acids. The Cholesterol is 
oxidized by Cholesterol Oxidase to yield 4-Cholesterol 3-one and hydrogen peroxide 
as by product. Hydrogen peroxide together with 4-aminoantipyrin and phenolic 
compound in the presence of peroxidase gives the colored complex. The intensity of 
the colour is proportional to the total cholesterol in the sample and is measured at 
550nm or with Green filter. 
Cholesterol ester + H2O         cholesterol esterase                   Cholesterol + Fatty acids 
Cholesterol + O2       cholesterol oxidase                 4-Cholesterol-3-one- H2O2 
2H2O2 + Phenol + 4-aminoantipyrine       peroxidase          Red quinine + 4H2O 
Requirements 
 Enzyme reagents  
 HDL precipitate reagent 
Procedure    
              1ml of enzyme reagent and 10µl of test or standard were mixed well and 
incubated at 37ºC for 5mins. The absorbance of test and standard were measured at 
505nm or using Green filter. 
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Calculation 
                                                        Absorbance of test 
Cholesterol conc.mg/dl   =                                                        conc. of standard (200) 
                                                       Absorbance of standard 
HDL Cholesterol 
(49)
 
Procedure 
Step 1 
              200µl of serum and 300µl of HDL ppt reagent were mixed well and allowed 
to for 10mins. Then the mixture was centrifuged at 3000rpm for 10mins and the 
supernatant was separated. 
Step 2 
              1ml of enzyme reagent and 100µl of supernatant from step A were mixed 
together and incubated for 5mins at 37ºC. The absorbance is read at 505nm. 
Calculation 
                                                           Absorbance of test   
HDL Cholesterol conc.mg/dl =                                                   conc. of standard (50) 
                                                      Absorbance of standard 
 
TRIGLYCERIDE 
(50) 
              In human nutrition, triglyceride is the most prevalent glycerol esters 
encountered. They constitute 95% of tissue storage fat are the predominant form of 
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glycerol ester found in plasma. The investigation of triglyceride is part of the overall 
evaluation of lipids disorders. 
Principle 
              Triglyceride + H2O              LPL                          Glycerol + free fatty acid 
              Glycerol + ATP                   GK                   Glycerol -3- phosphate + ADP 
              Glycerol-3-phosphate + O2            GPO                 DAP + H2O2 
                   H2O2 + 4AAP + 3, 5-DHBS      peroxidase        Quinoeimine Dye + 2H2O2 
Requirements  
 Pipes buffer pH 7.0 
 4-AAP 0.4mmol/l 
 Magnesium 2mmol/l 
 ATP 2mmol/l 
 GK 
 POD 
 LPL 
 GPO 
 Surfactants 
 Procedure 
              1ml of reagent mixed with 10µl of sample and incubated for 5min at 37ºC. 
Then the absorbance is measured at 505nm. 
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Calculation 
              Triglyceride mg/dl = AX/AS   Concentration of standard 
Where, AX- Absorbance of sample, AS- Absorbance of standard 
HISTOPATHOLOGICAL STUDIES 
            At the end of 21st day, all the animals were sacrificed to collect the pancreas 
and liver. The organs were rinsed in ice cold 0.9% saline and were fixed in 10% 
formalin embedded in paraffin and cut into 5 µm thick sections in a microtome. 
Sections were mounted on glass slides using standard techniques. After staining with 
Hematoxylin-Eosin, the section were examined under 100X magnification and 
photographed under a light microscope equipped for photography (Olympus CK 40). 
STATISTICAL ANALYSIS 
               The results were expressed as Mean ± SD. All the parameters were analysed 
by one way ANOVA. The probability values p<0.01, p<0.001 are considered as 
statistically significant. The statistical analysis was performed by using vasarstats one 
way ANOVA online software (htttp..//vasarstats.net/anova1u.html). 
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6. RESULTS 
 6.1 PRELIMIARY PHYTOCHEMICAL ANALYSIS 
  Table 1: Preliminary phytochemical analysis of ethanolic extract of Cassia 
fistula L. 
TEST 
 
RESULTS 
 
Test for Flavonoids 
a) Shinado’s test 
b) Sodium hydroxide test 
 
Present 
Present 
Test for Alkaloids 
a) Dragendroff’s test 
b) Mayer’s test 
c) Wagner’s test 
 
Absent 
Absent 
Absent 
Test for Steroids 
      Salkowskis test 
 
Absent 
Test for Tannins 
     With lead acetate 
 
Absent 
Test for Saponins: 
      Foam test 
 
Absent 
Test for Terpenoids 
      With Tin and thionyl 
chloride 
 
Absent 
Test for Glycosides 
a) Borntrager’s test 
b) Liermann-burchard’s 
test 
c) Legal’s test 
 
Present 
Present 
Present 
Test for Carbohydrates 
        Molish’s test  
 
Absent 
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 6. 2 ACUTE TOXICITY STUDY 
               Table 2: Acute toxicity study of ethanolic root extract of Cassia fistula L. 
S.NO 
 
               PARAMETERS              RESULTS 
1. Toxic signs Absent 
2. Pre-terminal deaths Nil 
3. Body weight No specific change 
4. Motor activity Normal 
5. Tremors  Absent 
6. Convulsions  Absent 
7. Straub reaction  Absent 
8. Righting reflex  Present 
9. Lacrimation and salivation   Normal 
10. Unusual vocalization  Absent 
11. Sedation  Absent 
12. Body temperature  Normal 
13. Analgesia  Absent 
14. Ptosis  Absent 
15. Diarrhea  Absent 
16. Skin colour  Normal 
18. Respiration  Normal 
19. Scratching  Absent 
20. Grooming  Absent 
21. Aggressiveness and restlessness Absent 
 
             Animals were observed for behavioral signs of toxicity like motor activity, 
tremor, etc., and no significant toxic signs were observed during 14 days. The results 
of the acute toxicological studies revealed that the administration of ethanolic extract 
of Cassia fistula L. by oral route upto 2000mg/kg/b.w did not produce any mortality 
and it was tolerated. 
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 6.3 IN VITRO ANTIDIABETIC STUDIES 
GLUCOSE DIFFUSION ASSAY 
Table 3: Mean glucose intensity in the external solution of various extracts of 
Cassia fistula L. at different time intervals               
Time in 
hours 
Control (in the 
absence of 
extract) 
n-Hexane 
extract 
(50mg/ml) 
Ethyl acetate 
extract 
(50mg/ml) 
Ethanol 
extract 
(50mg/ml) 
1h 134.33±1.20 105.33±1.20
a 
94±1.15
a 
83.33±0.88
a 
3h 201.33±1.76 184±1.15
a 
155.33±0.88
a 
116.33±0.88
a 
5h 244.33±1.76 216±1.15
a 
193.66±0.88
a 
157.33±1.20
a 
24h 312.33±2.02 293±1.15
a 
256.33±1.45
a 
228.66±1.76
a 
27h 316.66±1.76 303.33±1.20
a 
262.33±0.88
a 
232±2.18
a 
                         Glucose values are expressed as mean ±SD 
                          a -p<0.001- compared to control 
 
 
Figure 1: Mean glucose intensity in the external solution of various extracts of 
Cassia fistula L. 
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                 Cassia fistula L. extracts the concentration of glucose into the external 
solution by retarding its diffusion through membrane. After 27 hrs the control showed 
316.66mg/dl of glucose in the external solution whereas the Cassia fistula ethanolic 
extract after 27 hrs showed 232mg/dl of glucose. Cassia fistula L. ethanolic extract 
possessed a good effect in glucose diffusion and was showed highest activity.          
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INHIBITION OF ALPHA-AMYLASE ENZYME 
 
Table 4: Invitro anti diabetic activity of root of Cassia fistula L. in alpha amylase 
enzyme inhibition method 
S.No Concentration 
of sample     
(µg/ml) 
%  Inhibition 
 
n-hexane Ethyl acetate Ethanol 
1 200 10.02 23.09 31.10 
2 400 14.21 25.49 36.34 
3 600 18.50 29.06 39.09 
4 800 22.19 31.67 41.48 
5 1000 26.34 35.64 46.71 
6 1200 30.63 37.39 49.14 
                                             
Figure 2: % inhibition of alpha amylase Enzyme 
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              Cassia fistula L. ethanolic extract was a dose dependent increase in 
percentage inhibitory activity against alpha-amylase enzyme. At a concentration of 
200µg/ml of plant extract showed a percentage inhibition 31.10% and for 1200µg/ml 
of plant extract showed inhibition of 49.14%. It showed highest activity at 
concentration of 1200µg/ml.  
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6.4 IN VIVO ANTIDIABETIC ACTIVITY 
Table 5: Effect of ethanolic extract of Cassia fistula L. on body weight in STZ 
induced diabetic rats. 
GROUP TREATMENT AVERAGE BODY WEIGHT IN DAYS (gm) 
1
st 
Day 7
th
 Day 14
th 
Day 21
st
 Day 
1. Normal control 145.83±3.6 
 
149.83±0.75 150.5±2.58 151.66±3.01 
2. Diabetic 
control 
STZ (45mg/kg) 
 
153.66±2.80
a
 
 
147.5±2.42
c
 
 
145±1.41
a 
 
134.66±3.32
a
 
3. Glibenclamide 
(5mg/kg) 
 
162.66±3.93
a
 
 
159±1.78
a
 
 
155.83±2.32
a
 
 
151.33±1.21
a
 
4. Cassia fistula L 
extract 
200mg/kg 
 
149.83±1.60
b
 
 
143.8±1.21
c
 
 
142.83±1.16
b
 
 
137.83±1.17
c
 
5. Cassia fistula L 
extract 
400mg/kg 
 
157.16±2.31
c
 
 
145±1.41
c 
 
143±1.67
c 
 
138.5±1.04
c
 
Data were expressed as mean ± SD, n=6 
c   
p<0.05 significant 
b   
p<0.01 most significant 
a   
p<0.001 highly significant 
 
Diabetic control was compared with normal, Experimental groups were 
compared with diabetic control. (Table 5) shows the mean body weight during the 
study period of all groups. The mean body weight was decrease in G2, G3 and G4 & 
G5 on 21
st
 day when comparing with 1
st
 day of treatment. 
G2 showed significant reduction in body weight p< 0.05. When compared 
within all group. 
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Figure 3: Body weight of STZ induced diabetic Wistar rats after 3 weeks of 
treatment with ethanolic extract of Cassia fistula L. 
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Table 6: Effect of ethanolic extract of Cassia fistula L. on whole blood glucose in 
STZ induced diabetic rats. 
GROUP TREATMENT WHOLE BLOOD GLUCOSE (mg/dl) 
1
st 
Day 7
th
 Day 14
th
 Day 21
st
 Day 
1. Normal 
control 
 
77.66±1.37 
 
86.33±0.81 
 
92.66±2.16 
 
98.17±2.13 
2. Diabetic 
control 
STZ (45mg/kg) 
 
382.66±1.75
a
 
 
398.16±1.72
a
 
 
415.01±1.41
a
 
 
430.66±0.81
a
 
3. Glibenclamide 
(5mg/kg) 
 
369.16±0.76
b
 
 
232.5±2.16
b
 
 
216.16±1.16
a
 
 
154.83±0.75
a
 
4. Cassia fistula L 
extract 
(200mg/kg) 
 
434.16±0.75
a
 
 
220.33±1.86
a
 
 
156±1.14
a
 
 
95.83±1.73
a
 
5. Cassia fistula L 
extract 
(400mg/kg) 
 
372.16±1.47
a
 
 
234.16±1.94
a
 
 
155±1.18
a
 
 
95.16±1.5
a 
Values are expressed as mean ±SD, n=6.  
          c 
p<0.05 significant, 
b 
p<0.01 most significant 
     
a 
p<0.001 highly significant 
          Diabetic control was compared with normal, Experimental groups were 
compared with diabetic control. 
Within group analysis 
          The mean blood glucose level showed a significant reduction in G3, G4, and 
G5 on 21
st
 day when compared with 1
st
 day of treatment. 
Between group analysis 
          When comparing with G2, the mean blood glucose was lowered in G3, G4 and 
G5 on day 21
st 
day of treatment. 
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          On comparing control group G1 with G2, G3, G4 and G5 a statistically 
significant (p<0.001) difference was observed in G2. 
         On comparing G2 with G3, G4 and G5 a statistically significant (p< 0. 001) 
difference was seen in both the groups of the animals. 
 
Figure 4: Mean blood glucose level 
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                                                           LIPID PROFILE 
            Table 7: Effect of ethanolic root extract of Cassia fistula L. on lipid profile 
Group Treatment Cholesterol Triglycerides HDL 
1. Normal 
Control 
 
118.8±1.16 
 
 
100.16±1.17 
 
23±0.89 
2. Diabetic control 
STZ (45mg/kg) 
 
237.5±1.87
a 
 
 
238±1.67
a 
 
18.83±0.75
a 
3. Glibenclamide 
(5mg/kg) 
 
119.83±1.47
a 
 
 
97.83±1.47
a 
 
29.16±1.72
a 
4. Cassia fistula 
extract 
(200mg/kg) 
 
123.33±1.36
a 
 
98.83±1.47
a 
 
23.5±1.04
a 
5. Cassia fistula 
Extract 
(400mg/kg) 
 
120.33±1.03
a 
 
97.9±1.5
a 
 
24.66±1.03
a 
Values are expressed as mean ±SD, n=6.  
                                          
c 
p<0.05 significant 
                                                               b 
p<0.01 most significant 
                                          
a 
p<0.001 highly significant 
 
         Diabetic control was compared with normal, Experimental groups were 
compared with diabetic control. 
         The mean cholesterol and triglyceride levels were higher in GP2, than the group 
with GP3, GP4 & GP5. 
         A significant (p< 0.001) decrease in Triglyceride & cholesterol level was 
observed in G2 Vs G3, G4 and G5. 
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 Figure 5: Effect of ethanolic root extract of Cassia fistula L. on lipid profile level  
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HISTOPATHOLOGICAL STUDY OF LIVER 
(PORTAL TRAID) 
 
      1. NORMAL CONTROL                           2.  DISEASE CONTROL 
      
3. GLIBENCLAMIDE                         4. Cassia fistula 200mg/kg 
                                          
5. Cassia fistula 400mg/kg 
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HISTOPATHOLOGICAL OBSERVATION 
1. In normal control group animal the histopathology of liver showed portal triad 
surrounded by cords of hepatocytes. 
2. Glibenclamide treated animal the histology of liver showed moderate 
periportal inflammation when compared with normal control. 
3. STZ induced diabetic rat showed no periportal inflammation. 
4. Cassia fistula L. ethanolic root extract (200mg/kg and 400mg/kg) treated 
animals showed very mild periportal inflammation compared with diabetic rat. 
5. Cassia fistula L. ethanolic root extract (200mg/kg and 400mg/kg) treated 
animals showed mild periportal inflammation when compared with normal 
control as well as standard drug. 
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HISTOPATHOLOGICAL STUDY OF PANCREAS 
 
      
1. NORMAL CONTROL                                2. DISEASE CONTROL 
      
3. GLIBENCLAMIDE                               4. Cassia fistula 200mg/kg 
                            
                             5. Cassia fistula 400mg/kg 
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HISTOPATHOLOGICAL OBSERVATION 
1. The pancreatic islets of langerhans of normal rat showing alpha cells and beta 
cells. 
2. STZ induced diabetic damaged pancreatic islets showing reduced size and 
increased damaged beta cells. 
3. Glibenclamide (5mg/kg) treated pancreatic islet showed better restoration, 
when compared to the STZ induced diabetic control rats. 
4. Cassia fistula extract (200mg/kg) treated pancreatic islet showed partial better 
restoration, when compared to the STZ induced diabetic rats. 
5. Cassia fistula extract (400mg/kg) treated pancreatic islets partial restoration of 
beta cells. The animals revealed better restoration from the STZ induced 
damage when compared to control and disease control as well as 200mg/kg of 
extract treated animal. 
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7. DISCUSSION 
            Diabetes is a chronic metabolic disorder affecting a major proportion of the 
population worldwide. A sustained reduction in hyperglycemic will decrease the risk 
of developing micro vascular disease and reduce their complications
 (51)
. The 
conventional therapies for diabetes have many shortcomings like side effects and high 
rate of secondary failure. On the other hand herbal extracts are expected to have 
similar efficacy without side effects as that of conventional drugs. The present 
investigation reports that antidiabetic effect of Cassia fistula on streptozotocin (STZ) 
induced diabetic rats 
(52)
.  
             STZ produces oxygen radicals in the body, which cause pancreatic injury and 
could be responsible for increased blood sugar seen in animals 
(53)
. Pancreas has a 
relatively weak defense system against oxidative stress, which can be externally 
strengthened. Antioxidants such as N-acetylcystine and dietary antioxidant such as 
Vitamin C and E have shown to be beneficial in protecting the β-cells from glucose 
toxicity in diabetes
 (54)
. 
              Medicinal plants could be considered as potential sources for providing a 
reasonable amount of the required elements other than diet to the patients of diabetes 
mellitus. Several controlled clinical trials of trace element supplements for glycemic 
control revealed the beneficial role for supplementation for the control and 
management of diabetes 
(55-57)
.  
              Over 150 plants extracts and some of the active principle including 
flavonoids are known to be used for the treatment of diabetes. In our study the root of 
the plant extract of Cassia fistula L. indicates the presence of secondary metabolites 
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like flavonoids, glycosides were used. The presence of these phytochemicals in high 
concentration account for the significant hypoglycemic effect of Cassia fistula L.  
              Cassia fistula L. is a tropical herb/frob which has been traditionally used in 
the management DM 
(39)
. This present study has been undertaken to evaluate the 
preliminary phytochemical analysis, in vitro, acute toxicity and in vivo studies in 
diabetic Wistar rats. 
             The phytochemical analysis of ethanolic extract of Cassia fistula L. showed 
the presence of flavonoids, glycoside (table 1).  The medicinal plants with 
hypoglycemic and anti-diabetic effect usually contain high concentration of 
flavonoids 
(58)
. 
              Acute toxicity study revealed that the ethanolic extracts of Cassia fistula L. 
was relatively non toxic up to 2000mg/kg/b.w, p.o indirectly pronouncing safety 
profile of the extract (table 2). 
              The present finding reveals that Cassia fistula L. efficiently inhibit alpha-
amylase enzyme in vitro in a dose dependent manner. The ethanolic extracts from 
Cassia fistula L root showed a dose dependent inhibitory effect of alpha –amylase 
activity. There was a dose-dependent increase in percentage inhibitory activity against 
alpha-amylase enzyme. At a concentration of 200µg/ml of plant extract showed a 
percentage inhibition of 31.10% and for 1200µg/ml plant extract showed inhibition 
of 49.14 % (table 4). 
               The in vitro antidiabetic evaluation was assessed by glucose diffusion assay. 
Cassia fistula L. ethanolic extract showed maximum decrease in glucose diffusion 
when compared to control values. Glucose diffusion is useful in vitro index to predict 
the effect of plant fibers on the delay in glucose absorption in GI tract. In addition to 
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glucose adsorption, the retardation in glucose diffusion might be attributed to the 
physical obstacle presented by fiber particles towards glucose molecules and 
entrapment of glucose within the network formed by fibers. The effect of various 
extracts on glucose diffusion inhibition was depicted (table 3). At the end of 27 hrs, 
glucose movement of control (without plant extract) in the external solution had 
reached a plateau with a mean glucose concentration above 300mg/dl (316.66±.76). It 
was evident from the graph (figure 1) that the ethanol extract were found to be potent 
inhibitor of glucose diffusion (p< 0.001)   compared to control. The ethanolic extract 
was found to be more potent than other extracts showing the lowest mean glucose 
concentration of 208±1.15mg/dl at the end of 27 hrs (table3). 
             When compared with n-hexane and ethyl acetate extract of Cassia fistula L., 
ethanolic extract showed good activity in alpha-amylase enzyme inhibition and 
glucose diffusion method. So ethanolic extract of Cassia fistula L was selected for in 
vivo study.  
             In diabetic blood glucose is not utilized by tissue resulting in hyperglycemia. 
The fatty acids from adipose tissue are mobilized for energy purpose. The reduction in 
weight is due to loss in muscle adipose tissue, protein and fatty acids. Studies have 
also reported significant weight reduction in untreated diabetic rats 
(58, 59)
. 
              Control animal were found to be almost stable in their body weight but 
diabetic induced rats showed significant reduction in body weight. The administration 
of Cassia fistula L. root extracts (200 & 400mg/kg) and Glibenclamide (5mg/kg) to 
the diabetic rats restored the changes in the body weight (table 5). On comparing 
200mg Vs 400mg/kg weight of Cassia fistula L. and there was a significant difference 
in body weight (p< 0.05) was observed. The dose dependant antidiabetic property of 
the ethanolic extract of Cassia fistula L. exhibited slight improvement in body weight. 
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            Plants may act on blood glucose through different mechanisms, some of them 
may have insulin-like substances
 (60)
.Some may stimulate β-cells to produce more 
insulin and other may increase β-cells in the pancreas by activating regeneration of 
pancreatic cells. The fiber of the plants may also interfere with carbohydrate 
adsorption; thereby affecting blood glucose
 (63)
. 
            In this present study, after the administration of extract (200 & 400mg/kg), the 
fall in fasting blood glucose was evident at the end. Fall in fasting blood glucose 
levels progressively retained till the end of 3
rd
 week. 
            When the reduction of blood glucose level with 200mg/kg & 400mg/kg were 
compared, there was a statistically significant reduction in blood glucose levels 
(p<0.001) was exhibited with 400mg/kg of the ethanolic root extract Cassia fistula L. 
(table 6). 
            Diabetes induce hyperlipidemia due to excess mobilization of fats from 
adipose tissue to the under utilization of glucose. High levels of triglyceride, LDL and 
VLDL also reported and have been associated with heart disease, insulin resistance 
and diabetes mellitus 
(61)
. 
            The levels of total serum cholesterol and triglycerides were raised in diabetic 
rats which were lowered significantly with the treatment of Glibenclamide and 
ethanolic extract of Cassia fistula Linn. (Table7). On comparing groups 3,4,5 with 
group 2 there was a significant reduction in total cholesterol, triglyceride and HDL 
levels (p<0.001) in Streptozotocin induced diabetic rats and its hypolipidemic effect 
could represent a protective mechanism against the development of atherosclerosis 
which is usually associated with diabetes. 
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             The rejuvenation of β cells in diabetes has been studied in different animal 
models. The total β-cells mass reflects the balance between the renewal and loss of 
these cells. Previous studies  suggested that regeneration of islets of β-cells following 
destruction by streptozotocin, may be the primary cause of the recovery of 
streptozotocin injected guinea pigs from the effect of the drug 
(62)
. 
             Histological section of endocrine regions of pancreas of STZ induced diabetic 
rats revealed a significant reduction in the size of the islets when compared to that of 
normal groups. Further the study revealed the presence of damaged β-cell population. 
This damage of the β-cells due to STZ induction. The reduction in β-cell number can 
be as low 50% during diabetes. On the other hand, studies on the supplementation of 
extracts the diabetic rats revealed restoration of size of the islets along with β-cells 
repair. This recovery of the β-cells was recorded as dose dependant that is from 
200mg to 400mg/kg body weight of the Cassia fistula L. extract given animals. The 
plant extract fed animals revealed better restored β-cells of pancreas from the STZ 
induced damage. The restoration of β-cells was evident at higher dose level of 
400mg/kg body weight extract fed groups. 
            The data of this present studies may suggested that ethanolic extract of Cassia 
fistula L. has beneficial effects in diabetes mellitus holding the hope for anti-diabetic 
drugs. 
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8. CONCLUSION 
 
 From the present study we conclude that the preliminary phytochemical analysis of 
Cassia fistula L. indicated the presence of flavonoids, Glycosides. 
 In vitro Glucose diffusion properties of Cassia fistula L. extract was evaluated using 
dialysis membrane and GOD-POD kit. 
 In vitro alpha-amylase enzyme inhibition of Cassia fistula L. extract was evaluated. 
 Ethanolic extract of Cassia fistula L. was safe in dose upto 2000mg/kg by acute 
toxicity study and there was no toxic effects produced. 
 The ethanolic extract of Cassia fistula L. (200mg/kg and 400mg/kg) exhibited 
significant reduction in triglyceride & cholesterol and also reduction in the body 
weight in streptozotocin induced diabetic rats. 
 In vivo studies of Cassia fistula L. ethanolic extract revealed the glucose lowering 
effect. Thus it was concluded that the ethanolic extract of Cassia fistula L. has anti-
diabetic activity. 
 In this present study was exhibited significant inhibition activity of ethanolic root 
extract of Cassia fistula L. by using in vitro  -amylase and glucose diffusion assay, 
so further the compound isolation, purification and characterization which is 
responsible for inhibiting activity, has to be done for the usage of antidiabetic agent. 
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